Mobileye Scores Huge Deal with Top U.S. Automaker for Smart Driver Safety Tech
Mobileye just won a huge production program for its smart Driver Monitoring System (DMS) with a top U.S. automaker.
NOTRELOAD AI
Insmed’s Arikayce Scores Big Win in Phase 3 Study – Could Soon Treat Early-Stage MAC Lung Disease
Insmed announced positive topline results from the Phase 3b ENCORE study of Arikayce in newly diagnosed MAC lung disease. The drug showed statistically significant improvements in respiratory symptoms and culture conversion rates vs standard therapy.
Apogee’s Long-Acting Eczema Shot Keeps Skin Clear with Just 2 Injections a Year
Apogee Therapeutics’ Phase 2 data show zumilokibart maintains strong skin clearance and itch relief in moderate-to-severe eczema for 52 weeks with dosing every 3 or 6 months.
Bipartisan Senate Bill Targets Sports Betting on Prediction Markets Like Kalshi and Polymarket
Sens. Schiff & Curtis introduce legislation to ban CFTC-regulated prediction markets from offering sports wagers, closing a loophole amid state clashes.
Morgan Stanley Doubles Down on Venture Global, Upgrading to Overweight Amid Qatar LNG Crisis
Morgan Stanley double-upgrades Venture Global to Overweight after damage to Qatar’s Ras Laffan LNG plant creates a global supply shortfall and upside price risks. It also upgraded Cheniere Energy.
Hedge Fund Billionaire Presses Trump to Unlock $370 Billion Fannie-Freddie Windfall
Bill Ackman lobbies Trump officials to retire $370B govt stake in Fannie Mae & Freddie Mac, calling it his top 2026 idea for massive Treasury gains and shareholder wins.